| Mrs Alison Tobias, MS CCC-SLP | |
|
194 Bloomfield Ave Apt 2c, Montclair, NJ 07042-4894 | |
| (973) 479-1115 | |
| Not Available |
| Full Name | Mrs Alison Tobias |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 194 Bloomfield Ave Apt 2c, Montclair, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255931770 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP01474 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Alison Tobias, MS CCC-SLP 194 Bloomfield Ave Apt 2c, Montclair, NJ 07042-4894 Ph: (973) 479-1115 | Mrs Alison Tobias, MS CCC-SLP 194 Bloomfield Ave Apt 2c, Montclair, NJ 07042-4894 Ph: (973) 479-1115 |
News Archive
The Female Health Company announced that it has fulfilled an order for 3.5 million FC2 Female Condoms to be distributed for HIV/AIDS prevention to attendees at the 2010 World Cup. The 2010 World Cup will take place in The Republic of South Africa from June 11, 2010 to July 11, 2010.
Scientists and physicians at UC San Francisco (UCSF) are leading a $26 million, multi-institutional research program in which they will employ advanced technology to characterize human brain networks and better understand and treat a range of common, debilitating psychiatric disorders, focusing first on anxiety disorders and major depression.
The Vasculitis Foundation is pleased to announce it has selected two new research studies on eosinophilic granulomatosis with polyangiitis (EGPA) /Churg Strauss for funding in the amount of $98,000.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference, and miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA -based therapeutics for cardiovascular and muscle disease, announced today that they have entered into a research collaboration.
The authors find that average out-of-pocket spending is expected to decrease for all groups considered in the analysis, although decreases in out-of-pocket spending will be largest for those who would otherwise be uninsured.
› Verified 7 days ago
Ayana Webb, M.A., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 33 Hillside Ave Apt 7, Montclair, NJ 07042 Phone: 732-675-0279 | |
Mary Gagliardotto, MA, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17 Watchung Plz, Montclair, NJ 07042 Phone: 973-744-0804 | |
Cara Cilento, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 51 Upper Montclair Plz, Montclair, NJ 07043 Phone: 973-519-1989 | |
Brielle Korin Stern, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17 Watchung Plz, Montclair, NJ 07042 Phone: 973-744-0804 | |
Ciera Marie Iandiorio, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 34 Valley Rd Apt 204, Montclair, NJ 07042 Phone: 973-349-0323 | |
Janel Modoski, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 395 Claremont Ave Apt 2, Montclair, NJ 07042 Phone: 609-529-7194 | |
Eileen Anne Fasanella, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2 Woodmont Rd, Montclair, NJ 07043 Phone: 973-818-2164 |